Modeling transdermal drug release

被引:169
作者
Kalia, YN [1 ]
Guy, RH
机构
[1] Univ Geneva, Ctr Interuniv Rech & Enseignement, CH-1211 Geneva 4, Switzerland
[2] Univ Lyon, F-74166 Archamps, France
[3] Univ Geneva, Fac Sci, Pharm Sect, Pharm Galen Lab, CH-1211 Geneva 4, Switzerland
[4] Univ Lyon 1, Lab Rech & Dev Pharm Galen Ind, Lyon, France
关键词
transdermal drug delivery; diffusion;
D O I
10.1016/S0169-409X(01)00113-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stratum corneum forms the outermost layer of the skin and is essentially a multilamellar lipid milieu punctuated by protein-filled corneocytes that augment membrane integrity and significantly increase membrane tortuosity. The lipophilic character of the stratum corneum, coupled with its intrinsic tortuosity, ensure that it almost always provides the principal barrier to the entry of drug molecules into the organism; the only exceptions being highly lipophilic species which might encounter problems at the stratum corneum-viable epidermis interface where they must partition into a predominantly aqueous environment. Drugs can be administered either as suspensions or as solutions and the formulation can range in complexity from a gel or an ointment to a multilayer transdermal patch. In this review we describe the theoretical principles used to describe transdermal release and we show that relatively simple membrane transport models based on the appropriate solution to Fick's second law of diffusion can be used to explain drug release kinetics into this complex biological membrane, (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:159 / 172
页数:14
相关论文
共 17 条
[1]   INTERFACIAL TRANSFER STUDIED WITH A ROTATING DIFFUSION CELL [J].
ALBERY, WJ ;
BURKE, JF ;
LEFFLER, EB ;
HADGRAFT, J .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS I, 1976, 72 :1618-1626
[2]   TRANSPORT AND KINETICS IN 2 PHASE SYSTEMS [J].
ALBERY, WJ ;
COUPER, AM ;
HADGRAFT, J ;
RYAN, C .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS I, 1974, 70 :1124-1131
[3]   DIFFUSION-MODEL FOR DRUG RELEASE FROM SUSPENSIONS .1. THEORETICAL CONSIDERATIONS [J].
AYRES, JW ;
LINDSTROM, FT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (05) :654-662
[4]   Release rates from topical formulations containing drugs in suspension [J].
Bunge, AL .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :141-148
[5]  
Cleary G., 1993, TOPICAL DRUG BIOAVAI
[6]  
Crank J., 1979, MATH DIFFUSION
[7]  
FLYNN GL, 1985, TOPICS PHARM SCI 198, P313
[8]   RATE CONTROL IN TRANSDERMAL DRUG DELIVERY [J].
GUY, RH ;
HADGRAFT, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 82 (03) :R1-R6
[9]   A THEORETICAL DESCRIPTION RELATING SKIN PENETRATION TO THE THICKNESS OF THE APPLIED MEDICAMENT [J].
GUY, RH ;
HADGRAFT, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1980, 6 (3-4) :321-332
[10]   INVITRO ASSESSMENTS OF TRANSDERMAL DEVICES CONTAINING NITROGLYCERIN [J].
HADGRAFT, J ;
LEWIS, D ;
BEUTNER, D ;
WOLFF, HM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 73 (02) :125-130